[go: up one dir, main page]

NO315545B1 - Blanding med bestemt dose, av en angiotensinkonverterende enzyminhibitor ogav en kalsiumkanal antagonist, fremgangsmåte for fremstilling oganvendelse derav ved behandling av kardiovaskul¶re sykdommer - Google Patents

Blanding med bestemt dose, av en angiotensinkonverterende enzyminhibitor ogav en kalsiumkanal antagonist, fremgangsmåte for fremstilling oganvendelse derav ved behandling av kardiovaskul¶re sykdommer Download PDF

Info

Publication number
NO315545B1
NO315545B1 NO19982112A NO982112A NO315545B1 NO 315545 B1 NO315545 B1 NO 315545B1 NO 19982112 A NO19982112 A NO 19982112A NO 982112 A NO982112 A NO 982112A NO 315545 B1 NO315545 B1 NO 315545B1
Authority
NO
Norway
Prior art keywords
dose
nitrendipine
mixture
enalapril
treatment
Prior art date
Application number
NO19982112A
Other languages
English (en)
Norwegian (no)
Other versions
NO982112L (no
NO982112D0 (no
Inventor
Pedro Canovas Soler
Joaquin Delgadillo Duarte
Luis Manuel Micheto Escuder
Original Assignee
Vita Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8299270&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO315545(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vita Lab filed Critical Vita Lab
Publication of NO982112D0 publication Critical patent/NO982112D0/no
Publication of NO982112L publication Critical patent/NO982112L/no
Publication of NO315545B1 publication Critical patent/NO315545B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
NO19982112A 1997-05-13 1998-05-08 Blanding med bestemt dose, av en angiotensinkonverterende enzyminhibitor ogav en kalsiumkanal antagonist, fremgangsmåte for fremstilling oganvendelse derav ved behandling av kardiovaskul¶re sykdommer NO315545B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009701017A ES2125198B1 (es) 1997-05-13 1997-05-13 Asociacion a dosis fija de un inhibidor de la enzima convertidora de angiotensina y de un antagonista de los canales de calcio, procedimiento para su preparacion y su utilizacion para el tratamiento de enfermees cardiovasculares.

Publications (3)

Publication Number Publication Date
NO982112D0 NO982112D0 (no) 1998-05-08
NO982112L NO982112L (no) 1998-11-16
NO315545B1 true NO315545B1 (no) 2003-09-22

Family

ID=8299270

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19982112A NO315545B1 (no) 1997-05-13 1998-05-08 Blanding med bestemt dose, av en angiotensinkonverterende enzyminhibitor ogav en kalsiumkanal antagonist, fremgangsmåte for fremstilling oganvendelse derav ved behandling av kardiovaskul¶re sykdommer

Country Status (23)

Country Link
EP (1) EP0884054B9 (ja)
JP (1) JP3576806B2 (ja)
CN (1) CN1146418C (ja)
AR (1) AR011730A1 (ja)
AT (1) ATE236653T1 (ja)
AU (1) AU735404B2 (ja)
BR (1) BR9805597A (ja)
CA (1) CA2234899C (ja)
CZ (1) CZ292616B6 (ja)
DE (1) DE69813083T2 (ja)
DK (1) DK0884054T3 (ja)
ES (2) ES2125198B1 (ja)
HU (1) HUP9801075A3 (ja)
IL (1) IL124253A (ja)
NO (1) NO315545B1 (ja)
NZ (1) NZ330447A (ja)
PL (1) PL192117B1 (ja)
PT (1) PT884054E (ja)
RU (1) RU2182002C2 (ja)
SK (1) SK284337B6 (ja)
TR (1) TR199800847A3 (ja)
TW (1) TW562679B (ja)
ZA (1) ZA983806B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU226950B1 (en) * 1999-11-03 2010-03-29 Richter Gedeon Nyrt The magnesium salt of enalapril and antihypertensive pharmaceutical composition containing it
MXPA02010040A (es) * 2000-04-11 2004-10-15 Sankyo Co Composiciones farmaceuticas estabilizadas que contienen bloqueadores de canal de calcio.
CN100509058C (zh) * 2001-01-26 2009-07-08 先灵公司 过氧化物酶体增殖物激活受体(ppar)活化剂和甾醇吸收抑制剂的组合药以及对于血管适应症的治疗
ME00076B (me) * 2002-12-16 2011-02-10 Kissei Pharmaceutical Lijek u čvrstom obliku za oralnu primjenu
RU2618471C2 (ru) * 2012-12-03 2017-05-03 Закрытое Акционерное Общество "Вертекс" Пероральная фармацевтическая композиция диуретика и ингибитора АПФ в микронизированной форме, лекарственное средство и его применение
CN109350733A (zh) * 2018-06-08 2019-02-19 山东理工职业学院 一种马来酸依那普利片剂的制备方法
CN109985013B (zh) * 2019-05-10 2021-08-10 河北君圣药业有限公司 一种尼群地平分散片及其制备方法
CN115501224A (zh) * 2022-10-09 2022-12-23 南昌大学第一附属医院 马来酸依那普利叶酸片联合通心络在制备治疗高血压合并颈动脉硬化药物的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3437917A1 (de) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen Kombination von dihydropyridinen mit ace-hemmern sowie ihre verwendung in arzneimitteln
USH734H (en) * 1988-03-07 1990-02-06 E. R. Squibb & Sons, Inc. Method for inhibiting onset of or treating migraine headaches employing an ACE inhibitor
JPH01275529A (ja) * 1988-03-21 1989-11-06 E R Squibb & Sons Inc 晩発性運動障害の抑制治療剤
CA2007525A1 (en) * 1989-01-30 1990-07-30 Zola P. Horovitz Method for facilating dieting employing an ace inhibitor
US5160744A (en) * 1991-06-27 1992-11-03 Alza Corporation Verapmil therapy
US5246944A (en) * 1991-08-13 1993-09-21 Merck & Co., Inc. Quinoline angiotensin ii antagonists incorporating a substituted benzyl element
SI9111842A (sl) * 1991-11-25 1998-04-30 Krka Stabilna formulacija soli enalaprila, postopek za njeno pripravo in njena uporaba
SI9300504A (en) * 1993-09-28 1995-04-30 Krka Process for preparation solid dispersions and deposits of calcium antagonist dihidropyrimidine derivates and pharmaceutical compositions comprising the same
US5573780A (en) * 1995-08-04 1996-11-12 Apotex Usa Inc. Stable solid formulation of enalapril salt and process for preparation thereof

Also Published As

Publication number Publication date
BR9805597A (pt) 2000-04-11
CN1146418C (zh) 2004-04-21
AU735404B2 (en) 2001-07-05
ES2197443T3 (es) 2004-01-01
ES2125198A1 (es) 1999-02-16
DE69813083D1 (de) 2003-05-15
HUP9801075A3 (en) 2000-12-28
AU6597398A (en) 1998-11-19
DE69813083T2 (de) 2004-05-27
NO982112L (no) 1998-11-16
NO982112D0 (no) 1998-05-08
TR199800847A2 (xx) 1999-10-21
PL192117B1 (pl) 2006-09-29
DK0884054T3 (da) 2003-07-21
CZ292616B6 (cs) 2003-11-12
PT884054E (pt) 2003-08-29
RU2182002C2 (ru) 2002-05-10
NZ330447A (en) 1998-12-23
CA2234899A1 (en) 1998-11-13
TR199800847A3 (tr) 1999-10-21
TW562679B (en) 2003-11-21
JP3576806B2 (ja) 2004-10-13
JPH11124330A (ja) 1999-05-11
HUP9801075A2 (hu) 1999-01-28
EP0884054A2 (en) 1998-12-16
EP0884054B1 (en) 2003-04-09
EP0884054B9 (en) 2007-02-14
CN1212869A (zh) 1999-04-07
CZ138198A3 (cs) 1998-12-16
IL124253A (en) 2003-01-12
PL326246A1 (en) 1998-11-23
CA2234899C (en) 2004-08-10
ES2125198B1 (es) 1999-11-16
SK61698A3 (en) 1998-12-02
HU9801075D0 (en) 1998-07-28
SK284337B6 (sk) 2005-02-04
AR011730A1 (es) 2000-08-30
ATE236653T1 (de) 2003-04-15
EP0884054A3 (en) 2000-08-23
ZA983806B (en) 1999-02-19

Similar Documents

Publication Publication Date Title
CA2397262C (en) Use of central cannabinoid receptor antagonist for preparing medicines designed to facilitate smoking cessation
US20100047341A1 (en) Combined preparation for the treatment of cardiovascular diseases based on chronotherapy theory
US20050187262A1 (en) Compositions comprising (S)-amlodipine and an angiotensin receptor blocker and methods of their use
KR20040007420A (ko) 암로디핀 및 베나제프릴의 치료용 배합물
MX2011001461A (es) Uso de dronedarona para la preparacion de un medicamento para la prevencion de ictus o ataque isquemico transitorio.
PL206069B1 (pl) Tabletka dwuwarstwowa zawierająca cetyryzynę i pseudoefedrynę
AU2004283047B2 (en) Pharmaceutical composition comprising a selective I1 imidazoline receptor agonist and an angiotensin II receptor blocker
NO315545B1 (no) Blanding med bestemt dose, av en angiotensinkonverterende enzyminhibitor ogav en kalsiumkanal antagonist, fremgangsmåte for fremstilling oganvendelse derav ved behandling av kardiovaskul¶re sykdommer
KR101414814B1 (ko) 염산레르카니디핀 및 발사르탄을 포함하는 복합 제제 및 이의 제조방법
RU2336076C2 (ru) Пероральное лекарственное средство для восполнения дефицита магния в организме
US20100249103A1 (en) combination treatment
WO2009143662A1 (zh) 含钙通道阻滞剂和b族维生素的药物组合物及其用途
MXPA98003747A (en) Association at a fixed dose of an inhibitor of the angiotensin converter enzyme and an antagonist of calcium channels, a procedure for its preparation and its use for the treatment of cardiovascular diseases
US8470363B2 (en) Antihypertensive pharmaceutical composition
CN101690725A (zh) 治疗心血管疾病的药物组合物及其制备方法和用途
KR102267965B1 (ko) 베타 차단제, 전환 효소 억제제 및 항고혈압제 또는 nsaid를 포함하는 약학적 조성물
NZ192924A (en) Anti-hypertensive compositions containing endralazine, pendolol and a salidiuretic
CA2727957A1 (en) Pharmaceutical composition comprising levamlodipine and indapamide
JPH01283224A (ja) 抗高血圧の組み合わせ調合物
ITTO960379A1 (it) Composizione farmaceutica per malattie cardiovascolari e renali.
CA2498049A1 (en) At<sb>1</sb> receptor antagonists for preventing secondary strokes
SA98190540B1 (ar) جرعة مشتركة ثابتة تحتوي على مثبط لأنزيم تحويل الأنجيوتنسين وعلى عامل مضاد لقناة الكالسيوم لعلاج الأمراض القلبية الوعائية

Legal Events

Date Code Title Description
MK1K Patent expired